In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
The team utilized machine learning to analyze public data from the National Health and Nutrition Examination Survey.
Background Suicide rates have increased over the last couple of decades globally, particularly in the United States and among populations with lower economic status who present at safety-net ...
Researchers sought to determine an effective approach to predict postembolization fever in patients undergoing TACE.
Read more about AI-driven learning analytics struggle to deliver measurable gains in higher education on Devdiscourse ...
Morning Overview on MSN
Machine learning is turbocharging cheap lithium-ion battery design
Lithium-ion batteries have become the quiet workhorses of the energy transition, but the way they are designed and tested has ...
The Opioid Risk Tool for Opioid Use Disorder may help identify patients with chronic noncancer pain at increased risk for OUD ...
The ability to anticipate what comes next has long been a competitive advantage -- one that's increasingly within reach for developers and organizations alike, thanks to modern cloud-based machine ...
Impulse AI is building an autonomous machine learning engineer that turns data into production models from a simple prompt. Founded in 2025 and based in California, the company enables teams to build, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results